Close Menu
NEW YORK (GenomeWeb News) – Standard & Poor’s last night said that Life Technologies, the name of the combined Invitrogen and Applied Biosystems, will replace Applied Biosystems in the S&P 500 Index.
 
Invitrogen and ABI expect to close their $6.7 billion merger later this week, after which time they will operate under the Life Technologies name.
 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.